Lymphocyte chemoattractants (CXCL9 and CXCL13) as immune-activating factors revealed a high immune state of NAL-H and NAL-M, and they were highly significant predictors of therapy response.
← all excerpts
Characterization of Neoantigen Load Subgroups in Gynecologic and Breast Cancers.
1
—
—